134 related articles for article (PubMed ID: 14568811)
1. Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion.
Marcotte TD; Deutsch R; McCutchan JA; Moore DJ; Letendre S; Ellis RJ; Wallace MR; Heaton RK; Grant I;
Arch Neurol; 2003 Oct; 60(10):1406-12. PubMed ID: 14568811
[TBL] [Abstract][Full Text] [Related]
2. Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA.
Ellis RJ; Moore DJ; Childers ME; Letendre S; McCutchan JA; Wolfson T; Spector SA; Hsia K; Heaton RK; Grant I
Arch Neurol; 2002 Jun; 59(6):923-8. PubMed ID: 12056927
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group.
Ellis RJ; Hsia K; Spector SA; Nelson JA; Heaton RK; Wallace MR; Abramson I; Atkinson JH; Grant I; McCutchan JA
Ann Neurol; 1997 Nov; 42(5):679-88. PubMed ID: 9392566
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of HIV RNA and markers of immune activation as predictors of HIV-associated dementia.
Sevigny JJ; Albert SM; McDermott MP; McArthur JC; Sacktor N; Conant K; Schifitto G; Selnes OA; Stern Y; McClernon DR; Palumbo D; Kieburtz K; Riggs G; Cohen B; Epstein LG; Marder K
Neurology; 2004 Dec; 63(11):2084-90. PubMed ID: 15596754
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal serum HIV RNA quantification: correlation to viral phenotype at seroconversion and clinical outcome.
Katzenstein TL; Pedersen C; Nielsen C; Lundgren JD; Jakobsen PH; Gerstoft J
AIDS; 1996 Feb; 10(2):167-73. PubMed ID: 8838704
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment.
Spudich SS; Nilsson AC; Lollo ND; Liegler TJ; Petropoulos CJ; Deeks SG; Paxinos EE; Price RW
BMC Infect Dis; 2005 Nov; 5():98. PubMed ID: 16266436
[TBL] [Abstract][Full Text] [Related]
7. Effects of age at seroconversion and baseline HIV RNA level on the loss of CD4+ cells among persons with hemophilia. Multicenter Hemophilia Cohort Study.
Touloumi G; Hatzakis A; Rosenberg PS; O'Brien TR; Goedert JJ
AIDS; 1998 Sep; 12(13):1691-7. PubMed ID: 9764790
[TBL] [Abstract][Full Text] [Related]
8. AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: markers with reciprocal predictive value over time after seroconversion.
de Wolf F; Spijkerman I; Schellekens PT; Langendam M; Kuiken C; Bakker M; Roos M; Coutinho R; Miedema F; Goudsmit J
AIDS; 1997 Dec; 11(15):1799-806. PubMed ID: 9412697
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of serum HIV-RNA levels at virologic steady state after seroconversion: relation to CD4 cell count and clinical course of primary infection.
Pedersen C; Katzenstein T; Nielsen C; Lundgren JD; Gerstoft J
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Oct; 16(2):93-9. PubMed ID: 9358103
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression.
Cysique LA; Brew BJ
J Neurovirol; 2011 Apr; 17(2):176-83. PubMed ID: 21416169
[TBL] [Abstract][Full Text] [Related]
11. Viral dynamics and CD4+ T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern Africa.
Gray CM; Williamson C; Bredell H; Puren A; Xia X; Filter R; Zijenah L; Cao H; Morris L; Vardas E; Colvin M; Gray G; McIntyre J; Musonda R; Allen S; Katzenstein D; Mbizo M; Kumwenda N; Taha T; Karim SA; Flores J; Sheppard HW
AIDS Res Hum Retroviruses; 2005 Apr; 21(4):285-91. PubMed ID: 15943570
[TBL] [Abstract][Full Text] [Related]
12. Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group.
Ellis RJ; Deutsch R; Heaton RK; Marcotte TD; McCutchan JA; Nelson JA; Abramson I; Thal LJ; Atkinson JH; Wallace MR; Grant I
Arch Neurol; 1997 Apr; 54(4):416-24. PubMed ID: 9109743
[TBL] [Abstract][Full Text] [Related]
13. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.
Hecht FM; Wang L; Collier A; Little S; Markowitz M; Margolick J; Kilby JM; Daar E; Conway B; Holte S;
J Infect Dis; 2006 Sep; 194(6):725-33. PubMed ID: 16941337
[TBL] [Abstract][Full Text] [Related]
14. (1→3)-β-D-Glucan Levels Correlate With Neurocognitive Functioning in HIV-Infected Persons on Suppressive Antiretroviral Therapy: A Cohort Study.
Hoenigl M; de Oliveira MF; Pérez-Santiago J; Zhang Y; Morris S; McCutchan AJ; Finkelman M; Marcotte TD; Ellis RJ; Gianella S
Medicine (Baltimore); 2016 Mar; 95(11):e3162. PubMed ID: 26986173
[TBL] [Abstract][Full Text] [Related]
15. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study.
O'Brien TR; Blattner WA; Waters D; Eyster E; Hilgartner MW; Cohen AR; Luban N; Hatzakis A; Aledort LM; Rosenberg PS; Miley WJ; Kroner BL; Goedert JJ
JAMA; 1996 Jul; 276(2):105-10. PubMed ID: 8656501
[TBL] [Abstract][Full Text] [Related]
16. Immunological and virological activity of zalcitabine and zidovudine in combination in HIV-positive people with CD4 cell counts of between 200-500 cells/mm3.
Ibáñez A; Peraire J; Arnó A; Gutiérrez C; Cervantes M; Colomer J; Villalonga C; Camafort M; Ruiz L; Balaguer M; Vidal F; Richart C; Clotet B
Antivir Ther; 1997 Apr; 2(2):105-11. PubMed ID: 11322274
[TBL] [Abstract][Full Text] [Related]
17. Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy.
McArthur JC; McDermott MP; McClernon D; St Hillaire C; Conant K; Marder K; Schifitto G; Selnes OA; Sacktor N; Stern Y; Albert SM; Kieburtz K; deMarcaida JA; Cohen B; Epstein LG
Arch Neurol; 2004 Nov; 61(11):1687-96. PubMed ID: 15534180
[TBL] [Abstract][Full Text] [Related]
18. Rapid disease progression in human immunodeficiency virus type 1-infected seroconverters in India.
Mehendale SM; Bollinger RC; Kulkarni SS; Stallings RY; Brookmeyer RS; Kulkarni SV; Divekar AD; Gangakhedkar RR; Joshi SN; Risbud AR; Thakar MA; Mahajan BA; Kale VA; Ghate MV; Gadkari DA; Quinn TC; Paranjape RS
AIDS Res Hum Retroviruses; 2002 Nov; 18(16):1175-9. PubMed ID: 12487823
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine.
Foudraine NA; Hoetelmans RM; Lange JM; de Wolf F; van Benthem BH; Maas JJ; Keet IP; Portegies P
Lancet; 1998 May; 351(9115):1547-51. PubMed ID: 10326538
[TBL] [Abstract][Full Text] [Related]
20. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.
Sterling TR; Vlahov D; Astemborski J; Hoover DR; Margolick JB; Quinn TC
N Engl J Med; 2001 Mar; 344(10):720-5. PubMed ID: 11236775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
